 |
Humanized anti-human CD2 MAb |
|---|---|
| Trade Name | Medi-507 |
| Orphan Indication | For the induction of donor-specific immunologic unresponsiveness resulting in prophylaxis of organ rejection without the need for chronic immunosuppressive therapy, in patients receiving allogeneic renal transplants |
| USA Market Approval | USA |
| USA Designation Date | 1998-09-17 00:00:00 |
| Sponsor | Biotransplant, Inc.;Building 75, 3rd. Ave., Charlestown Navy Yard;Charlestown, Massachusetts, 02129 |
